182 related articles for article (PubMed ID: 34258910)
1. Prognostic implications of atrial fibrillation in patients with stable coronary artery disease: a systematic review and meta-analysis of adjusted observational studies.
Saglietto A; Varbella V; Ballatore A; Xhakupi H; Ferrari GM; Anselmino M
Rev Cardiovasc Med; 2021 Jun; 22(2):439-444. PubMed ID: 34258910
[TBL] [Abstract][Full Text] [Related]
2. Differential Prognostic Impact of Atrial Fibrillation in Hospitalized Heart Failure Patients With Preserved Ejection Fraction According to Coronary Artery Disease Status - Report From the Japanese Nationwide Multicenter Registry.
Temma T; Nagai T; Watanabe M; Kamada R; Takahashi Y; Hagiwara H; Koya T; Nakao M; Omote K; Kamiya K; Iwano H; Yamamoto K; Yoshikawa T; Saito Y; Anzai T
Circ J; 2020 Feb; 84(3):397-403. PubMed ID: 32009066
[TBL] [Abstract][Full Text] [Related]
3. Should the Presence or Extent of Coronary Artery Disease be Quantified in the CHA2DS2-VASc Score in Atrial Fibrillation? A Report from the Western Denmark Heart Registry.
Steensig K; Olesen KKW; Thim T; Nielsen JC; Jensen SE; Jensen LO; Kristensen SD; Bøtker HE; Lip GYH; Maeng M
Thromb Haemost; 2018 Dec; 118(12):2162-2170. PubMed ID: 30419601
[TBL] [Abstract][Full Text] [Related]
4. Impact of atrial fibrillation on clinical outcomes among patients with coronary artery disease undergoing revascularisation with drug-eluting stents.
Pilgrim T; Kalesan B; Zanchin T; Pulver C; Jung S; Mattle H; Carrel T; Moschovitis A; Stortecky S; Wenaweser P; Stefanini GG; Räber L; Meier B; Jüni P; Windecker S
EuroIntervention; 2013 Jan; 8(9):1061-71. PubMed ID: 23339812
[TBL] [Abstract][Full Text] [Related]
5. Impact of coronary artery disease and revascularization on recurrence of atrial fibrillation after catheter ablation: Importance of ischemia in managing atrial fibrillation.
Hiraya D; Sato A; Hoshi T; Watabe H; Yoshida K; Komatsu Y; Sekiguchi Y; Nogami A; Ieda M; Aonuma K
J Cardiovasc Electrophysiol; 2019 Sep; 30(9):1491-1498. PubMed ID: 31190437
[TBL] [Abstract][Full Text] [Related]
6. Comparison of prognosis and outcomes of catheter ablation versus drug therapy in patients with atrial fibrillation and stable coronary artery disease: A prospective propensity-score matched cohort study.
Cui YK; Dong JZ; Du X; Hu R; He L; Jia CQ; Li X; Wu JH; Yu RH; Long DY; Ning M; Sang CH; Jiang CX; Bai R; Wen SN; Liu N; Li SN; Wang W; Guo XY; Zhao X; Zuo S; Chen X; Huang ST; Wu HS; Tang RB; Ma CS
Clin Cardiol; 2021 Oct; 44(10):1422-1431. PubMed ID: 34318505
[TBL] [Abstract][Full Text] [Related]
7. Baseline atrial fibrillation is associated with contrast-induced nephropathy after cardiac catheterization in coronary artery disease: Systemic review and meta-analysis.
Prasitlumkum N; Kanitsoraphan C; Kittipibul V; Rattanawong P; Chongsathidkiet P; Cheungpasitporn W
Clin Cardiol; 2018 Dec; 41(12):1555-1562. PubMed ID: 30328129
[TBL] [Abstract][Full Text] [Related]
8. Sex differences in stroke and major adverse clinical events in patients with atrial fibrillation: A systematic review and meta-analysis of 993,600 patients.
Marzona I; Proietti M; Farcomeni A; Romiti GF; Romanazzi I; Raparelli V; Basili S; Lip GYH; Nobili A; Roncaglioni MC
Int J Cardiol; 2018 Oct; 269():182-191. PubMed ID: 30025657
[TBL] [Abstract][Full Text] [Related]
9. Adverse clinical events in Japanese atrial fibrillation patients with and without coronary artery disease-findings from the SAKURA AF Registry.
Fukamachi D; Okumura Y; Yokoyama K; Matsumoto N; Tachibana E; Kuronuma K; Oiwa K; Matsumoto M; Nishida T; Kojima T; Hanada S; Nomoto K; Sonoda K; Arima K; Kogawa R; Takahashi F; Kotani T; Ohkubo K; Fukushima S; Itou S; Kondo K; Chiku M; Ohno Y; Onikura M; Hirayama A;
Curr Med Res Opin; 2019 Dec; 35(12):2053-2062. PubMed ID: 31355684
[No Abstract] [Full Text] [Related]
10. Prevalence of atrial fibrillation dependent on coronary artery status: Insights from the LIFE-Heart Study.
Kornej J; Henger S; Seewöster T; Teren A; Burkhardt R; Thiele H; Thiery J; Scholz M
Clin Cardiol; 2020 Dec; 43(12):1616-1623. PubMed ID: 33107623
[TBL] [Abstract][Full Text] [Related]
11. Atrial fibrillation in outpatients with stable coronary artery disease: results from the multicenter RECENT study.
Zielonka A; Tkaczyszyn M; Mende M; Nowak W; Rekucki K; Soczomski P; Zieliński M; Pociupany R; Wilkins A; Banasiak W; Ponikowski P; Jankowska EA
Pol Arch Med Wewn; 2015; 125(3):162-71. PubMed ID: 25644126
[TBL] [Abstract][Full Text] [Related]
12. Outcomes of anticoagulated patients with atrial fibrillation treated with or without antiplatelet therapy - A pooled analysis from the PREFER in AF and PREFER in AF PROLONGATON registries.
Patti G; Pecen L; Lucerna M; Huber K; Rohla M; Renda G; Siller-Matula J; Schnabel RB; Cemin R; Kirchhof P; De Caterina R
Int J Cardiol; 2018 Nov; 270():160-166. PubMed ID: 30220376
[TBL] [Abstract][Full Text] [Related]
13. Characteristics of coronary artery disease among patients with atrial fibrillation compared to patients with sinus rhythm.
Motloch LJ; Reda S; Larbig R; Wolff A; Motloch KA; Wernly B; Granitz C; Lichtenauer M; Wolny M; Hoppe UC
Hellenic J Cardiol; 2017; 58(3):204-212. PubMed ID: 28300667
[TBL] [Abstract][Full Text] [Related]
14. Thromboembolic events in atrial fibrillation: Different level of risk and pattern between peripheral artery disease and coronary artery disease.
Lin YS; Wu VC; Chen YL; Liu CH; Chen HC; Lee WC; Yang TY; Aboyans V; Chen MC
Arch Cardiovasc Dis; 2021 Mar; 114(3):176-186. PubMed ID: 33518472
[TBL] [Abstract][Full Text] [Related]
15. Associations of combined polygenic risk score and glycemic status with atrial fibrillation, coronary artery disease and ischemic stroke.
Kim J; Kim D; Bae HJ; Park BE; Kang TS; Lim SH; Lee SY; Chung YH; Ryu JW; Lee MY; Yang PS; Joung B
Cardiovasc Diabetol; 2024 Jan; 23(1):5. PubMed ID: 38172896
[TBL] [Abstract][Full Text] [Related]
16. The Intersection of Atrial Fibrillation and Coronary Artery Disease in Middle Eastern Patients. Analysis from the Jordan Atrial Fibrillation Study.
Hammoudeh A; Badaineh Y; Tabbalat R; Ahmad A; Bahhour M; Ja'ara D; Shehadeh J; Jum'ah MA; Migdad A; Hani M; Alhaddad IA
Glob Heart; 2024; 19(1):29. PubMed ID: 38505303
[TBL] [Abstract][Full Text] [Related]
17. Clinical effectiveness and safety of antazoline-based therapy in patients with stable coronary artery disease undergoing pharmacological cardioversion of short-duration atrial fibrillation in the emergency department.
Farkowski MM; Maciag A; Zurawska M; Kowalik I; Szwed H; Pytkowski M
Cardiovasc Ther; 2018 Dec; 36(6):e12469. PubMed ID: 30281920
[TBL] [Abstract][Full Text] [Related]
18. Association of Concomitant Coronary Artery Disease With Cardiovascular Events in Patients With Atrial Fibrillation - The Fushimi AF Registry.
Masunaga N; Ogawa H; Minami K; Ishigami K; Ikeda S; Doi K; Hamatani Y; Yoshizawa T; Ide Y; Fujino A; Ishii M; Iguchi M; Wada H; Hasegawa K; Tsuji H; Esato M; Abe M; Akao M;
Circ J; 2022 Jul; 86(8):1252-1262. PubMed ID: 35786691
[TBL] [Abstract][Full Text] [Related]
19. New-Onset Atrial Fibrillation After PCI or CABG for Left Main Disease: The EXCEL Trial.
Kosmidou I; Chen S; Kappetein AP; Serruys PW; Gersh BJ; Puskas JD; Kandzari DE; Taggart DP; Morice MC; Buszman PE; Bochenek A; Schampaert E; Pagé P; Sabik JF; McAndrew T; Redfors B; Ben-Yehuda O; Stone GW
J Am Coll Cardiol; 2018 Feb; 71(7):739-748. PubMed ID: 29447735
[TBL] [Abstract][Full Text] [Related]
20. Antithrombotic therapy in coronary artery disease patients with atrial fibrillation.
Wei L; Su E; Liu W; Xing W; Liu X; Zhang Y; Wang S; Cheng Q; Qi D; Gao C
BMC Cardiovasc Disord; 2020 Jul; 20(1):323. PubMed ID: 32631244
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
